Patrick Sun Xiong

Dr. Patrick Sun Xiong is an American physician and researcher known for his groundbreaking work in oncology, particularly in the development of innovative treatments for various types of cancer, including lung cancer and glioblastoma. Recently, he gained attention for his advocacy of the cancer drug Anktiva, which has received conditional approval from the Saudi Food and Drug Authority for treating metastatic non-small cell lung cancer (NSCLC). Dr. Xiong has emphasized the importance of this treatment in improving patient survival rates and has highlighted the need for similar approvals from regulatory bodies in the United States.